| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/13/2008 | US20080064646 Lactobacillus Fermentum N-Desoxyribosyl Transferases and the Use Thereof for Enzymatic Synthesis of 2', 3' - Didesoxynucleosides and 2',3'- Didehydro-2',3'- Didesoxynucleosides |
| 03/13/2008 | US20080064637 Before cardiopulmonary bypass surgery or coronary artery bypass grafting; injecting a polypeptide preferential inhibitor of kallikrein, rather than aprotinin |
| 03/13/2008 | US20080064633 Preventing fibronectin deposition and fibrosis; phospholipase A2 inhibition; cystic fibrosis |
| 03/13/2008 | US20080064631 T-cell receptors for use in diagnosis and therapy of cancers and autoimmune disease |
| 03/13/2008 | US20080064630 Prolonged circulation time; combined with such as human growth hormone or fragments; nucleic acid constructs, vectors, host cells; culturing and harvesting |
| 03/13/2008 | US20080064607 Dual-Labeled Molecular Constructs for Detection of Biochemical Reactions |
| 03/13/2008 | US20080064599 Transforming a cell with the Arabidopsis thaliana-derived deformylase gene, contacting the cell with actinonin to induce herbicide resistance, plant regeneration; selectively growing the herbicide resistant plant so actinonin can be applied |
| 03/13/2008 | US20080064117 Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents |
| 03/13/2008 | US20080064106 Lentiviral LTR-deleted vector |
| 03/13/2008 | US20080064104 Antagonists and agonists of ldcam and methods of use |
| 03/13/2008 | US20080064102 Transiently immortalized cells for use in gene therapy |
| 03/13/2008 | US20080064097 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 03/13/2008 | US20080064096 Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof |
| 03/13/2008 | US20080064095 Method for obtaining mastocyte lines from pig tissues and for producing heparin-type modules |
| 03/13/2008 | US20080064092 Single chain polypeptide fusion comprising non-cytotoxic protease and proteinase activated receptor ligands (PAR1) domains for use in treatment and prevention of allergies, respiratory system, arthritic, skin and fibrotic disorders |
| 03/13/2008 | US20080064091 Cassette for Nucleic Acid Expression in Plants |
| 03/13/2008 | US20080064084 Method For Producing Recombinant Trypsin |
| 03/13/2008 | US20080064083 Expression vector comprising bacterial nucleotide sequences for use in diagnosis, prevention and treatment of microorganismal infection |
| 03/13/2008 | US20080064081 Reducing antigenicity of viral protein via amino acid sequence variation; enhancing vector transferability during gene therapy |
| 03/13/2008 | US20080064078 Heat resistant vacuole transport protein for use as nanoactuator of micromachine or nanomachine |
| 03/13/2008 | US20080064074 Expression vector comprising nucleotide sequences coding decaprenyl diphosphate synthase for use in transformation and propagation of escherichia with enhanced coenzyme concentrations; cosmetics; nutraceuticals |
| 03/13/2008 | US20080064069 Protein comprising uridine diphosphate-glucose 4,6-dehydratase, uridine diphosphate-4-keto-6-deoxyglucose 3,5-epimerase and uridine diphosphate-4-keto-rhamnose 4-keto-reductase for use in glycoengineering of polypeptides |
| 03/13/2008 | US20080064067 Corynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins |
| 03/13/2008 | US20080064066 Modified human granulocyte-colony stimulating factor and process for producing same |
| 03/13/2008 | US20080064065 Non-activated polypeptides having a function of tissue regeneration and method for preparing the same |
| 03/13/2008 | US20080064064 Mannanases |
| 03/13/2008 | US20080064063 Compositions and methods for producing steviol and steviol glycosides |
| 03/13/2008 | US20080064061 Yeast Promoter |
| 03/13/2008 | US20080064059 In Vivo Site-Specific Incorporation of N-Acetyl-Galactosamine Amino Acids in Eubacteria |
| 03/13/2008 | US20080064056 Function homology screening |
| 03/13/2008 | US20080064054 Substrate for accurate monitoring/determining presence or absence of clostridial toxin |
| 03/13/2008 | US20080064053 Recombinant vector for detecting agents that cause or potentiate DNA damage and tissue targeted therapy |
| 03/13/2008 | US20080064031 Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction |
| 03/13/2008 | US20080064028 Quantitative Pcr Method of Detecting Specific Plant Genus in Food or Food Ingredient |
| 03/13/2008 | US20080063776 Carboxypeptidase of cocoa |
| 03/13/2008 | US20080063774 Multiple mutation variants of serine protease |
| 03/13/2008 | US20080063701 Lipids of a liposome comprising cationic N1-cholesteryloxycarbonyl-3,7-diazanononane-1,9-diamine and/or noncationic dioleoyl phosphatidylethanolamine and short interference RNA (siRNA) are coupled, reversibly or irreversibly, to one or more polymers; drug delivery; freeze drying |
| 03/13/2008 | US20080063691 Fatty Acid Desaturases From Primula |
| 03/13/2008 | US20080063662 Vaccine |
| 03/13/2008 | US20080063661 treating a wart with a fusion protein comprising (1) a heat shock protein and (2) a human papilloma virus (HPV) protein; Mycobacterium bovis heat shock protein; HPV is an E7 protein; cervical dysplasia, anal cancer, anal dysplasia |
| 03/13/2008 | US20080063656 Adenoviral Vector Compositions |
| 03/13/2008 | US20080063655 nucleic acid sequences encoding a 30 kD Brachyspira hyodysenteriae lipoprotein; host cell; new locus comprising four genes has now surprisingly been found; swine dysentery |
| 03/13/2008 | US20080063653 vector-based vaccine may well aid in the development of effective vaccines for a range of human cancers; nucleic acid; agonist polypeptide derived from a mucin tumor antigen; genetic vaccine |
| 03/13/2008 | US20080063651 therapeutic protein comprising a tenth domain of fibronectin type III; protein scaffold; antibody design; scaffold derived from a fibronectin type III (Fn3) or Fn3-like domain, function like natural or engineered antibodies; antibody mimics designed for optimal folding, stability, and solubility |
| 03/13/2008 | US20080063643 HLA-binding motif in its sequence; recognized by an HLA-A2- or HLA-A24-restricted cytotoxic T cell; nucleotide; antibody; vector; diagnosid and prognosis of hepatitis C virus infection |
| 03/13/2008 | US20080063641 Comprise a single antigen binding arm and an Fc region; exhibits enhanced stability in vivo compared to a Fab antibody fragment |
| 03/13/2008 | US20080063632 Recombinant host for producing l-asparaginase ii |
| 03/13/2008 | US20080063630 polynucleotides that code for polypeptides having activity for targeting heterogeneous polypeptides to the surfaces of cytoplasmic membranes, useful for analysis of proteind, delivery of cells expressing the polypeptide to a target site in vivo, preparation of an antibodies and vaccines, and gene therapy |
| 03/13/2008 | US20080063598 chimeric antibodies, fragments, polypeptides and derivatives that preferentially bind tumor associated antigens (AF-20), useful in the treatment and diagnosis of cancers |
| 03/13/2008 | DE112004002217T5 Proteinbildungskomplex mit einem c-Jun-Protein, Nucleinsäure, codierend denselben und Verfahren unter Verwendung desselben The same protein complex formation with a c-Jun protein, nucleic acid encoding the same and methods using |
| 03/13/2008 | CA2663390A1 Method for study, determination or evaluation by gene expression analysis |
| 03/13/2008 | CA2663388A1 Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof |
| 03/13/2008 | CA2663083A1 Modified human plasma polypeptide or fc scaffolds and their uses |
| 03/13/2008 | CA2663047A1 Therapeutic elastin-like polypeptide (elp) fusion proteins |
| 03/13/2008 | CA2662959A1 Sirna and methods of manufacture |
| 03/13/2008 | CA2662755A1 Suppressor trna transcription in vertebrate cells |
| 03/13/2008 | CA2662753A1 Hybrid suppressor trna for vertebrate cells |
| 03/13/2008 | CA2662752A1 Site specific incorporation of non-natural amino acids by vertebrate cells |
| 03/13/2008 | CA2662707A1 Split-core-particles for the presentation of foreign molecules, especially for vaccine applications, and method for their production |
| 03/13/2008 | CA2662693A1 Aptamers labelled with gallium-68 |
| 03/13/2008 | CA2662350A1 Antibodies to bone morphogenic proteins and receptors therefor and methods for their use |
| 03/13/2008 | CA2662340A1 Humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
| 03/13/2008 | CA2662041A1 Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disorders |
| 03/13/2008 | CA2661878A1 Anti-activin a antibodies and uses thereof |
| 03/13/2008 | CA2661308A1 Neukinase, a downstream protein of neuregulin |
| 03/13/2008 | CA2657132A1 Potexvirus-derived replicon for expressing heterologous genes in a plant |
| 03/13/2008 | CA2653696A1 Recombinant vaccine against bluetongue virus |
| 03/13/2008 | CA2653556A1 Method for determining fatty acid content in bovine intramuscular fat based on genotype of fatty acid synthase |
| 03/12/2008 | EP1897954A1 Methods and means for producing starch having at least one altered characteristic |
| 03/12/2008 | EP1897953A1 Potexvirus-derived replicon |
| 03/12/2008 | EP1897952A2 Methyltransferasegenes and uses thereof |
| 03/12/2008 | EP1897951A2 Composition and methods for producing steviol and steviol glycosides |
| 03/12/2008 | EP1897950A2 Human GIL-19/AE289 proteins and polynucleotides encoding same |
| 03/12/2008 | EP1897949A2 Human interleukin-B50. Therapeutic uses |
| 03/12/2008 | EP1897948A1 Mammalian transforming growth factor beta 9 |
| 03/12/2008 | EP1897947A2 IL-17 homologous polypeptides and therapeutic uses thereof |
| 03/12/2008 | EP1897946A2 IL-17 homologous polypeptides and therapeutic uses thereof |
| 03/12/2008 | EP1897945A2 IL-17 homologous polypeptides and therapeutic uses thereof |
| 03/12/2008 | EP1897944A2 IL-17 homologous polypeptides and therapeutic uses thereof |
| 03/12/2008 | EP1897943A2 IL-17 homologous polypeptides and therapeutic uses thereof |
| 03/12/2008 | EP1897942A1 Antisense oligonucleotides which combat aberrant splicing and methods of using the same |
| 03/12/2008 | EP1897941A1 Means for increasing intracellular levels of protoporphyrin IX and use thereof |
| 03/12/2008 | EP1897940A1 Composition and method for diagnosing esophageal cancer and metastasis of esophageal cancer |
| 03/12/2008 | EP1897939A2 Microorganism strain for producing recombinant proteins |
| 03/12/2008 | EP1897938A1 Polypeptide having an improved cytosine deaminase activity |
| 03/12/2008 | EP1897887A1 Split-core-particles for the presentation of foreign molecules, especially for vaccination purposes and methods for their preparation |
| 03/12/2008 | EP1897562A1 Aptamers labelled with Gallium-68 |
| 03/12/2008 | EP1897553A1 Inhibitor of stem cell proliferation and uses thereof |
| 03/12/2008 | EP1897552A1 Polymer-conjugated glycosylated neublastin |
| 03/12/2008 | EP1897548A1 T cell regulation |
| 03/12/2008 | EP1897540A2 Inhibition of STAT3 signal transduction for human cancer therapy |
| 03/12/2008 | EP1896611A2 Imethod, array, apparatus and test system to discriminate individuals |
| 03/12/2008 | EP1896605A2 Stimulation of pancreatic b cell proliferation |
| 03/12/2008 | EP1896596A2 Methods for altering the reactivity of plant cell walls |
| 03/12/2008 | EP1896595A2 Methods for improving crop plant architecture and yield |
| 03/12/2008 | EP1896594A2 Improved methods for the production of stably transformed, fertile zea mays plants |
| 03/12/2008 | EP1896593A1 Enhancing vegetative protein production in transgenic plant cells using seed specific promoters |
| 03/12/2008 | EP1896592A2 Constructs and methods for generating plants exhibiting altered plasmodesmatal conductance |
| 03/12/2008 | EP1896591A2 Gene expression technique |
| 03/12/2008 | EP1896590A2 Serum-free stable transfection and production of recombinant human proteins in human cell lines |